Ann Surg Oncol

1. BREEZE S, Peterson C, Moncrieff M
   ASO Author Reflections: A Simplified Classification System for In-Transit Melanoma Metastases.
   Ann Surg Oncol. 2025 Nov 4. doi: 10.1245/s10434-025-18657.
   

   >> Share

   
   
2. ROBINSON TP, Kaiser KN, Ruedinger B, Hyngstrom J, et al
   ASO Visual Abstract: National Evaluation of the Management of Melanoma Patients with Multiple Positive Sentinel Lymph Nodes.
   Ann Surg Oncol. 2025 Nov 3. doi: 10.1245/s10434-025-18651.
   

   >> Share

   
   
3. ROBINSON TP, Kaiser KN, Ruedinger B, Hyngstrom J, et al
   National Evaluation of the Management of Melanoma Patients with Multiple Positive Sentinel Lymph Nodes.
   Ann Surg Oncol. 2025 Nov 1. doi: 10.1245/s10434-025-18466.
   

   >> Share

   
   

   
   Br J Cancer

4. SKARIN NORDENVALL A, Persson F, Martling A, Nordenskjold M, et al
   Risk of malignant melanoma and colorectal cancer in Birt-Hogg-Dube syndrome - a matched cohort study.
   Br J Cancer. 2025 Nov 5. doi: 10.1038/s41416-025-03258.
   

   >> Share

   
   

   
   Br J Dermatol

5. KAHLER S, Primiero C, Mothershaw A, Jayasinghe D, et al
   3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk.
   Br J Dermatol. 2025 Nov 3:ljaf440. doi: 10.1093.
   

   >> Share

   
   
6. LIU Y, Tan L
   A Missing Piece in the Cutaneous Melanoma Puzzle: Metabolic Reprogramming Driven by Loss of TET2/5hmC.
   Br J Dermatol. 2025 Nov 3:ljaf442. doi: 10.1093.
   

   >> Share

   
   

   
   J Am Acad Dermatol

7. PULAVARTY A, Maas D, Li R, Juarez MC, et al
   Utilization of Mohs micrographic surgery for acral lentiginous melanoma: A retrospective cohort study of the National Cancer Database (NCDB) 2004-2022.
   J Am Acad Dermatol. 2025 Nov 3:S0190-9622(25)03135.
   

   >> Share

   
   

   
   J Immunother

8. KALININA A, Tilova LR, Kazansky D, Khromykh L, et al
   Immunoregulatory Cyclophilin A Reprograms the Tumor Immune Microenvironment by Changing the Activation and Exhaustion Profile of T Cells and NK Cells in the Model of Melanoma B16 in Vivo.
   J Immunother. 2025 Nov 3. doi: 10.1097/CJI.0000000000000586.
   

   >> Share

   
   

   
   J Surg Oncol

9. JONSSON EL, Fraser Hill WK, Saayman M, Yakaback S, et al
   Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node-Positive Melanoma: Feasibility, Safety, and Early Outcomes.
   J Surg Oncol. 2025 Nov 5. doi: 10.1002/jso.70127.
   

   >> Share

   
   

   
   Nat Rev Cancer

10. SENFT D
    Melanomagenesis antagonizes stem cell ageing.
    Nat Rev Cancer. 2025 Nov 3. doi: 10.1038/s41568-025-00891.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

11. SONG K, Nguyen DC, Wang Y, Jokonya S, et al
    Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses.
    Proc Natl Acad Sci U S A. 2025;122:e2409978122.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share